Should biologics for psoriasis be interrupted in the era of COVID-19?

Title
Should biologics for psoriasis be interrupted in the era of COVID-19?
Authors
Keywords
-
Journal
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Volume 82, Issue 5, Pages 1217-1218
Publisher
Elsevier BV
Online
2020-03-20
DOI
10.1016/j.jaad.2020.03.031

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now